Eric Dobmeier is an accomplished biotechnology executive with extensive leadership experience across multiple organizations. Currently serving as Director at Structure Therapeutics and Venture Partner at Samsara BioCapital, Dobmeier's previous roles include Director and Advisor at ProfoundBio, Chief Operating Officer at Seagen, President & Chief Executive Officer at Chinook Therapeutics, and Executive positions at multiple biotechnology firms. Significant achievements include guiding Seagen through substantial growth and the successful launch of ADCETRIS, as well as leading Chinook Therapeutics in developing novel therapies for chronic kidney disease. Dobmeier also holds board positions at several biotechnology companies, focusing on innovative treatments for cancer, viral diseases, and autoimmune conditions. Academic qualifications include an A.B. in History from Princeton University and a J.D. from the University of California, Berkeley - School of Law.
This person is not in any teams
This person is not in any offices